Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Retrospective Assessment of OviTex PRS (OviTex)

NCT: NCT05736848 · ACTIVE_NOT_RECRUITING

NCT IDNCT05736848
StatusACTIVE_NOT_RECRUITING
Start Date2022-09-27
Completion2026-12-31
SponsorTela Bio Inc (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this retrospective-prospective, observational study is to evaluate the safety profile overall and within two device types of OviTex PRS in previous pre-pectoral or sub-pectoral implant-based breast reconstructions.

Frequently Asked Questions

What is A Retrospective Assessment of OviTex PRS (OviTex)?

A Retrospective Assessment of OviTex PRS (OviTex) is a clinical trial registered under NCT05736848. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05736848?

The current status of NCT05736848 (A Retrospective Assessment of OviTex PRS (OviTex)) is: ACTIVE_NOT_RECRUITING.

When did A Retrospective Assessment of OviTex PRS (OviTex) start?

A Retrospective Assessment of OviTex PRS (OviTex) started on 2022-09-27.

Related Devices

K214070OviTex PRS (Long Term Resorbable)Tela Bio K241126OviTex PRSTELA Bio, Inc. K243595OviTex PRS (Long-Term Resorbable)TELA Bio, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑